The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy

Author:

Hasegawa Shinichiro1,Wada Hiroshi1,Kubo Masahiko1,Mukai Yosuke1,Mikamori Manabu1,Akita Hirofumi1,Matsuura Norihiro1,Kitakaze Masatoshi1,Masuike Yasunori1,Sugase Takahito1,Shinno Naoki1,Kanemura Takashi1,Hara Hisashi1,Sueda Toshinori1,Nishimura Junichi1,Yasui Masayoshi1,Omori Takeshi1,Miyata Hiroshi1,Ohue Masayuki1

Affiliation:

1. Osaka International Cancer Institute

Abstract

Abstract Background The clinical significance of the lymph node ratio (LNR), the number of metastatic lymph nodes per dissected lymph node, has not been sufficiently clarified in ampullary cancer. Methods Among patients diagnosed histopathologically with ampullary cancer between 1980 and 2018, the study included 106 who underwent pathological radical resection by pancreaticoduodenectomy. The relationships between the LNR and metastatic lymph node sites and prognosis were examined. Results Multivariate analysis revealed that sex and lymph node metastasis were independent prognostic factors. In the 46 patients (43%) with metastatic lymph nodes, the LNR in the recurrence group was significantly higher than that in the non-recurrence group (0.15 ± 0.11 vs. 0.089 ± 0.071, p = 0.025). The receiver operating characteristic curve demonstrated that the LNR cut-off value, 0.07 (area under the curve = 0.70, sensitivity 81%, specificity 56%), was a significant indicator for recurrence (22% vs. 61%, p = 0.016) and prognosis (5-year survival: 48% vs. 83%, p = 0.028). Among the metastatic lymph node sites in the 46 positive cases, lymph node metastases developed from the peripancreatic head region (80%, 37/46) to the superior mesenteric artery (33%, 15/46) and para-aortic (11%, 5/46) regions. Conclusion Lymph node metastasis is an independent prognostic factor, and the LNR is a significant indicator for recurrence and prognosis in patients with ampullary cancer.

Publisher

Research Square Platform LLC

Reference33 articles.

1. Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges;Rizzo A;Curr Oncol,2021

2. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012;Hester CA;J Surg Oncol,2019

3. The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma;Zimmermann C;Sci Rep,2019

4. Imamura T, Yamamoto Y, Sugiura T, et al. The prognostic relevance of the new, 8th ed. of the Union for International Cancer Control Classification of TNM Staging for ampulla of Vater carcinoma. Ann Surg Oncol. 2019; 26: 1639–48.

5. Factors predictive of survival in ampullary carcinoma;Howe JR;Ann Surg,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3